中文名 | 2-甲基-8-羟基-4-喹唑啉酮 |
英文名 | 8-HYDROXY-2-METHYL-4(3H)-QUINAZOLINONE |
别名 | 2-甲基-8-羟基-4-喹唑啉酮 8-羟基-2-甲基-4-喹唑啉酮 8-羟基-2-甲基喹唑啉-4(3H)-酮 8-羟基-2-甲基-4(3H)-喹唑啉酮 |
英文别名 | NU1025 8-HYDROXY-2-METHYLQUINAZOLINE-4-ONE 8-HYDROXY-2-METHYLQUINAZOLIN-4[3H]-ONE 8-hydroxy-2-methyl-1H-quinazolin-4-one 8-HYDROXY-2-METHYL-4(3H)-QUINAZOLINONE |
CAS | 90417-38-2 |
化学式 | C9H8N2O2 |
分子量 | 176.17 |
密度 | 1.42 |
熔点 | 253-258°C |
溶解度 | 溶于DMSO |
存储条件 | −20°C |
外观 | solid,颜色 off-white |
物化性质 | 生物活性 NU1025 (NSC 696807)是一种有效的 PARP 抑制剂,IC50 为 400 nM。 |
靶点 | IC50: 400 nM (PARP) Ki: 48 nM (PARP) |
危险品标志 | Xn - 有害物品 |
风险术语 | 22 - 吞食有害。 |
安全术语 | 26 - 不慎与眼睛接触后,请立即用大量清水冲洗并征求医生意见。 |
WGK Germany | 3 |
海关编号 | 29335990 |
上游原料 | 氢氧化钠 四氢呋喃 N,N-二甲基甲酰胺 氯化亚砜 无水硫酸镁 吡啶 氮 氢气 乙酰乙酸乙酯 3-甲氧基-2-硝基苯甲酸 |
参考资料 展开查看 | 1: Kaundal RK, Shah KK, Sharma SS. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation. Life Sci. 2006 Nov 10;79(24):2293-302. Epub 2006 Aug 2. PubMed PMID: 16935310. 2: Bowman KJ, Newell DR, Calvert AH, Curtin NJ. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. Br J Cancer. 2001 Jan 5;84(1):106-12. PubMed PMID: 11139322; PubMed Central PMCID: PMC2363607. 3: Bowman KJ, White A, Golding BT, Griffin RJ, Curtin NJ. Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. Br J Cancer. 1998 Nov;78(10):1269-77. PubMed PMID: 9823965; PubMed Central PMCID: PMC2063197. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 5.676 ml | 28.382 ml | 56.763 ml |
5 mM | 1.135 ml | 5.676 ml | 11.353 ml |
10 mM | 0.568 ml | 2.838 ml | 5.676 ml |
5 mM | 0.114 ml | 0.568 ml | 1.135 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!